CDEK
← All organizations

Bausch & Lomb

For profitContributed to NMEWebsite ↗

Also known as: BAUSCH AND LOMB | BAUSCH AND LOMB INC | Bausch & Lomb Incorporated | Baush and Lomb

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 1990

First marketed drug

Aug 17, 1978

First NDA

Dec 29, 1989

Last known activity

Oct 24, 2025

Acquired by Bausch Health Companies on Aug 6, 2013

Timeline

1850s

  1. Jan 1, 1853

    Bausch & Lomb— Founded

1980s

  1. Jul 8, 1987

    Pharmafair— Acquired

  2. Dec 29, 1989

    metipranolol— NDA Organization

1990s

  1. Apr 29, 1994

    cyclopentolate— Marketing Organization

2000s

  1. Feb 19, 2008

    eyeonics, Inc.— Acquired

2010s

  1. Jan 1, 2012

    ISTA Pharmaceuticals— Acquired

  2. Nov 8, 2012

    Technolas Perfect Vision— Acquired

  3. Apr 5, 2013

    bromfenac— NDA Secondary Org

  4. Aug 6, 2013

    Bausch Health Companies— Acquired By

Drugs by trial phase (42 distinct, 131 trials)

Phase 1 (3 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (58)

Subsidiaries (4 direct, 4 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Rochester, NY, US Jan 1, 1853
First NDA
Dec 29, 1989
Last known activity
Oct 24, 2025

Notes

Acquired by Valeant 28 May 2013